Showing 1 to 1 of 1 results
forbes.com
🌐 85% Global Worthiness


Waystar's Acquisition and Strong Q2 Results Signal Potential for Stock Rerating
Waystar, a healthcare payment software provider, is acquiring Iodine Software for $1.25 billion, expanding its market and boosting margins; exceeding Q2 revenue guidance suggests a potential 2025 revenue upgrade; the stock trades at a significant discount to its sector on a PEG basis.
Waystar's Acquisition and Strong Q2 Results Signal Potential for Stock Rerating
Waystar, a healthcare payment software provider, is acquiring Iodine Software for $1.25 billion, expanding its market and boosting margins; exceeding Q2 revenue guidance suggests a potential 2025 revenue upgrade; the stock trades at a significant discount to its sector on a PEG basis.
Progress
48% Bias Score
Good Health and Well-being
Showing 1 to 1 of 1 results